5 completed, 1 available, 1 terminated. 3 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Terminated 1 |
| Phase 1 | 2 | Completed 2 |
| Phase 3 | 1 | Completed 1 |
Follow pritelivir: new trials by email Literature Review of pritelivir trials Research Report on pritelivir
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Thorough QT/QTc of Pritelivir in Healthy Subjects Pritelivir and moxifloxacin placebo, Pritelivir placebo, moxifloxacin and moxifloxacin placebo, Pritelivir placebo, moxifloxacin placebo and moxifloxacin - Healthy Subjects | Phase 1 | Completed | AiCuris Anti-infective Cures AG | 64 | 2022-12-04 | 2025-03-14 |
| Potential Influence of Esomeprazole on the Pharmacokinetics of Pritelivir Pritelivir, ESO and pritelivir - HSV Infection | Phase 1 | Completed | AiCuris Anti-infective Cures AG | 16 | 2020-07-13 | 2024-02-22 |
| Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Subjects Pritelivir, Investigator's choice - HSV Infection | Phase 3 | Completed | AiCuris Anti-infective Cures AG | 158 | 2017-05-08 | 2026-06-12 |
| Trial on Efficacy and Safety of Pritelivir Ointment for Treatment of Labial Herpes Pritelivir 5% w/w ointment, Pritelivir ointment matching placebo, Zovirax® cream - Herpes Labialis | Phase 2 | Completed | AiCuris Anti-infective Cures AG | 362 | 2016-11-29 | 2021-07-13 |
| Safety and Efficacy Comparator Trial of a New Drug Against Genital Herpes AIC316, Valacyclovir - Genital Herpes | Phase 2 | Terminated | AiCuris Anti-infective Cures AG | 91 | 2012-10-01 | 2023-04-21 |
| Safety and Efficacy Study for a New Antiviral Drug to Treat Genital Herpes Type 2 AIC316, Placebo - HSV-2 | Phase 2 | Completed | AiCuris Anti-infective Cures AG | 156 | 2010-03-01 | 2023-04-21 |
| Expanded Access Intermediate Size Treatment Protocol: Pritelivir for Immunocompromised Subjects with Treatment Resistant Herpes Simplex Virus Type 1 or 2 Pritelivir - HSV | Available | AiCuris Anti-infective Cures AG | 2025-02-10 |
Herpes Simplex (3) · Herpes Genitalis (1) · Herpes Labialis (1)
AiCuris Anti-infective Cures AG (7)
United States (5) · United Kingdom (2) · Argentina (1) · Australia (1) · Belgium (1) · Canada (1) · France (1) · Georgia (1) · Germany (1) · Greece (1) · Israel (1) · Italy (1) · Mexico (1) · Switzerland (1) · Ukraine (1)